Case study illustrating the WHO IPCS guidance on characterization and application of physiologically based pharmacokinetic models in risk assessment.

Autor: Meek, M.E. (Bette)1 bmeek@uottawa.ca, Barton, Hugh A.2 habarton@alum.mit.edu, Bessems, Jos G.3 jos.bessems@rivm.nl, Lipscomb, John C.4 lipscomb.john@epa.gov, Krishnan, Kannan5 kannan.krishnan@umontreal.ca
Zdroj: Regulatory Toxicology & Pharmacology: RTP. Jun2013, Vol. 66 Issue 1, p116-129. 14p.
Databáze: Academic Search Ultimate
Externí odkaz: